InvestorsHub Logo
Followers 99
Posts 4467
Boards Moderated 0
Alias Born 09/02/2009

Re: None

Saturday, 08/12/2017 8:19:39 AM

Saturday, August 12, 2017 8:19:39 AM

Post# of 113617
Subject to obtaining the necessary financing, we now anticipate that Phase I clinical trials will commence in mid-2018 and we estimate that it will take 18 months to complete, at which time we expect to receive limited marketing approval for “compassionate-use” under the FDA and similar guidelines in Canada.


In addition, we believe that upon successful completion of Phase I Clinical Trials we may receive one or more offers from large pharmaceutical companies to buyout or license our drug at a significant premium.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News